| Sruthi Sakamuri, MD | |
|
2000 Washington St Ste 768, Newton, MA 02462-1645 | |
| (617) 332-2345 | |
| Not Available |
| Full Name | Sruthi Sakamuri |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 2000 Washington St Ste 768, Newton, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023541471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 287410 (Massachusetts) | Primary |
| Entity Name | Newton-wellesley Obstetrics & Gynecology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891711495 PECOS PAC ID: 1759483191 Enrollment ID: O20080228000082 |
News Archive
Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results, opening the door to larger scale investigation, according to new research from The University of Texas M. D. Anderson Cancer Center.
A new study has shown that patients with breast cancer may be at an increased risk of developing the heart condition atrial fibrillation (AF).
Future Science Group today announced the publication of a new article in Future Science OA, reporting data that explore the effect of frailty on the natural history of diabetes and the implications it will have for therapeutic plans in older people.
Previous studies have revealed the influence of unhealthy food environments on the population's eating behavior. Yet the socioeconomic differences in these environments and their influence on diet had never been studied previously.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sruthi Sakamuri, MD 2000 Washington St Ste 768, Newton, MA 02462-1645 Ph: (617) 332-2345 | Sruthi Sakamuri, MD 2000 Washington St Ste 768, Newton, MA 02462-1645 Ph: (617) 332-2345 |
News Archive
Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results, opening the door to larger scale investigation, according to new research from The University of Texas M. D. Anderson Cancer Center.
A new study has shown that patients with breast cancer may be at an increased risk of developing the heart condition atrial fibrillation (AF).
Future Science Group today announced the publication of a new article in Future Science OA, reporting data that explore the effect of frailty on the natural history of diabetes and the implications it will have for therapeutic plans in older people.
Previous studies have revealed the influence of unhealthy food environments on the population's eating behavior. Yet the socioeconomic differences in these environments and their influence on diet had never been studied previously.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
› Verified 9 days ago
Dr. Kathryn Montiel Davis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St Ste 768, Newton, MA 02462 Phone: 617-332-2345 Fax: 617-332-0435 | |
Heidi S Angle, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Newton, MA 02462 Phone: 617-332-2345 Fax: 617-332-0435 | |
Ann L Dolloff, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Suite 764, Newton, MA 02462 Phone: 617-965-7800 | |
Emily Y Newton-cheh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Ste 764, Newton, MA 02462 Phone: 617-965-7800 Fax: 617-965-4581 | |
Phyllis W Scherr, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Suite 760, Newton, MA 02462 Phone: 617-332-5551 | |
Keith Bryan Isaacson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-5205 |